These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6785782)

  • 21. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.
    Hoffman AF; van Horne CG; Eken S; Hoffer BJ; Gerhardt GA
    Exp Neurol; 1997 Sep; 147(1):130-41. PubMed ID: 9294410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamine.
    Olds ME; Fobes JL; Albert V
    Psychopharmacology (Berl); 1981; 73(1):31-3. PubMed ID: 6785786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior.
    Orr WB; Gardiner TW; Stricker EM; Zigmond MJ; Berger TW
    Brain Res; 1986 Jun; 376(1):20-8. PubMed ID: 3087583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
    Bruto V; Beauchamp C; Zacharko RM; Anisman H
    Psychopharmacology (Berl); 1984; 83(1):62-9. PubMed ID: 6429702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism.
    Laverty R; Taylor KM
    Br J Pharmacol; 1970 Dec; 40(4):836-46. PubMed ID: 5495179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
    van den Buuse M; Versteeq DH; de Jong W
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):469-76. PubMed ID: 3093124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
    Zigmond MJ; Stricker EM
    Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of forebrain noradrenaline innervation to the central circulatory effects of alpha-methyldopa and 6-hydroxydopamine.
    van den Buuse M; Head GA; Korner PI
    Brain Res; 1991 Feb; 541(2):300-8. PubMed ID: 1905177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
    Dunn AJ; Berridge CW
    Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
    Nobrega JN; Coscina DV
    Pharmacol Biochem Behav; 1986 Aug; 25(2):401-9. PubMed ID: 3094039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine.
    Fuchs V; Coper H
    Psychopharmacology (Berl); 1980 Feb; 67(2):181-8. PubMed ID: 6768093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor activity and alimentary behavior after radio-frequency and 6-OHDA lesions of lateral hypothalamus and substantia nigra in cats.
    Konopacki J
    Acta Neurobiol Exp (Wars); 1984; 44(1):17-28. PubMed ID: 6426254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraventricular 6-hydroxydopamine lowers isolation-induced fighting behavior in male mice.
    Crawley JN; Contrera JF
    Pharmacol Biochem Behav; 1976 Apr; 4(4):381-4. PubMed ID: 945581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feeding behavior after hypothalamic 6-hydroxydopamine injections.
    Leibowitz SF
    Appetite; 1984 Sep; 5(3):268-71. PubMed ID: 6441518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.